237 related articles for article (PubMed ID: 38385738)
1. Mapping niche-specific two-component system requirements in uropathogenic
Brannon JR; Reasoner SA; Bermudez TA; Comer SL; Wiebe MA; Dunigan TL; Beebout CJ; Ross T; Bamidele A; Hadjifrangiskou M
Microbiol Spectr; 2024 Apr; 12(4):e0223623. PubMed ID: 38385738
[TBL] [Abstract][Full Text] [Related]
2. Mapping Niche-specific Two-Component System Requirements in Uropathogenic
Brannon JR; Reasoner SA; Bermudez TA; Dunigan TL; Wiebe MA; Beebout CJ; Ross T; Bamidele A; Hadjifrangiskou M
bioRxiv; 2023 May; ():. PubMed ID: 37292752
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.
Conover MS; Hadjifrangiskou M; Palermo JJ; Hibbing ME; Dodson KW; Hultgren SJ
mBio; 2016 Apr; 7(2):e00104-16. PubMed ID: 27073089
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection.
Walters MS; Lane MC; Vigil PD; Smith SN; Walk ST; Mobley HL
mBio; 2012; 3(1):. PubMed ID: 22318320
[TBL] [Abstract][Full Text] [Related]
5. Adaptation of Arginine Synthesis among Uropathogenic Branches of the Escherichia coli Phylogeny Reveals Adjustment to the Urinary Tract Habitat.
Hibbing ME; Dodson KW; Kalas V; Chen SL; Hultgren SJ
mBio; 2020 Sep; 11(5):. PubMed ID: 32994329
[TBL] [Abstract][Full Text] [Related]
6. Plant phenolics inhibit focal adhesion kinase and suppress host cell invasion by uropathogenic
Lewis AJ; Richards AC; Mendez AA; Dhakal BK; Jones TA; Sundsbak JL; Eto DS; Rousek AA; Mulvey MA
Infect Immun; 2024 May; 92(5):e0008024. PubMed ID: 38534100
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.
Nagamatsu K; Hannan TJ; Guest RL; Kostakioti M; Hadjifrangiskou M; Binkley J; Dodson K; Raivio TL; Hultgren SJ
Proc Natl Acad Sci U S A; 2015 Feb; 112(8):E871-80. PubMed ID: 25675528
[TBL] [Abstract][Full Text] [Related]
8. DFI-seq identification of environment-specific gene expression in uropathogenic Escherichia coli.
Madelung M; Kronborg T; Doktor TK; Struve C; Krogfelt KA; Møller-Jensen J
BMC Microbiol; 2017 Apr; 17(1):99. PubMed ID: 28438119
[TBL] [Abstract][Full Text] [Related]
9. A novel two-component signaling system facilitates uropathogenic Escherichia coli's ability to exploit abundant host metabolites.
Cai W; Wannemuehler Y; Dell'anna G; Nicholson B; Barbieri NL; Kariyawasam S; Feng Y; Logue CM; Nolan LK; Li G
PLoS Pathog; 2013; 9(6):e1003428. PubMed ID: 23825943
[TBL] [Abstract][Full Text] [Related]
10. Flexible Metabolism and Suppression of Latent Enzymes Are Important for
Alteri CJ; Himpsl SD; Shea AE; Mobley HLT
J Bacteriol; 2019 Aug; 201(16):. PubMed ID: 31160397
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic Necrotizing Factor-1 (CNF1) does not promote E. coli infection in a murine model of ascending pyelonephritis.
Michaud JE; Kim KS; Harty W; Kasprenski M; Wang MH
BMC Microbiol; 2017 May; 17(1):127. PubMed ID: 28545489
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Adaptations of Uropathogenic
Mann R; Mediati DG; Duggin IG; Harry EJ; Bottomley AL
Front Cell Infect Microbiol; 2017; 7():241. PubMed ID: 28642845
[No Abstract] [Full Text] [Related]
13. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract.
Lane MC; Alteri CJ; Smith SN; Mobley HL
Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16669-74. PubMed ID: 17925449
[TBL] [Abstract][Full Text] [Related]
14. Virulence genes and phylogenetic groups of uropathogenic Escherichia coli isolates from patients with urinary tract infection and uninfected control subjects: a case-control study.
Rezatofighi SE; Mirzarazi M; Salehi M
BMC Infect Dis; 2021 Apr; 21(1):361. PubMed ID: 33865334
[TBL] [Abstract][Full Text] [Related]
15. BarA-UvrY two-component system regulates virulence of uropathogenic E. coli CFT073.
Palaniyandi S; Mitra A; Herren CD; Lockatell CV; Johnson DE; Zhu X; Mukhopadhyay S
PLoS One; 2012; 7(2):e31348. PubMed ID: 22363626
[TBL] [Abstract][Full Text] [Related]
16. CpxA Phosphatase Inhibitor Activates CpxRA and Is a Potential Treatment for Uropathogenic Escherichia coli in a Murine Model of Infection.
Fortney KR; Smith SN; van Rensburg JJ; Brothwell JA; Gardner JJ; Katz BP; Ahsan N; Duerfeldt AS; Mobley HLT; Spinola SM
Microbiol Spectr; 2022 Apr; 10(2):e0243021. PubMed ID: 35297652
[TBL] [Abstract][Full Text] [Related]
17. Identification and Characterization of a Phase-Variable Element That Regulates the Autotransporter UpaE in Uropathogenic Escherichia coli.
Battaglioli EJ; Goh KGK; Atruktsang TS; Schwartz K; Schembri MA; Welch RA
mBio; 2018 Aug; 9(4):. PubMed ID: 30087170
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic Assessment of Clinical Escherichia coli Isolates as an Indicator for Uropathogenic Potential.
Shea AE; Frick-Cheng AE; Smith SN; Mobley HLT
mSystems; 2022 Dec; 7(6):e0082722. PubMed ID: 36445110
[TBL] [Abstract][Full Text] [Related]
19. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
[TBL] [Abstract][Full Text] [Related]
20. Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection.
Schwartz DJ; Chen SL; Hultgren SJ; Seed PC
Infect Immun; 2011 Oct; 79(10):4250-9. PubMed ID: 21807904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
